Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/02/2000CA2369058A1 Synthetic gene for expressing active retroviral protein in eukaryotes
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367954A1 Dna molecules encoding human endothelin converting enzyme 3
11/02/2000CA2367750A1 Tribonectins
11/02/2000CA2367696A1 Method of diagnosing transmissible spongiform encephalopathies
11/02/2000CA2367594A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof
11/01/2000CN1272218A Retentate chromatography and protein chip arrays with applications in biology and medicine
11/01/2000CN1272140A Gene encoding protein having aurone synthesizing activity
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
11/01/2000CN1272138A Protease variants and compositions
11/01/2000CN1272137A Protease variants and compositions
11/01/2000CN1272135A Prokaryotic cell comprising two copies of gene transcribed in different directions
11/01/2000CN1272118A Collagen type I and type III adhesive compositions
11/01/2000CN1272115A Human VAMP-2 like gene (CBCBMH06)
11/01/2000CN1271777A Carrier for solubility expression of target protein
11/01/2000CN1271776A Process for identifying cordyceps
11/01/2000CN1271775A Plant cell identity system
11/01/2000CN1271735A Anti-neuroexcitation peptide of scorpion
10/2000
10/31/2000US6141657 Method and apparatus for identifying classifying or quantifying DNA sequences in a sample without sequencing
10/31/2000US6140613 PCR method for amplifying a gene using metallic sample container having inner surface coated with a resin or metal oxide
10/31/2000US6140555 Precipitating dna onto tungsten microprojectiles of about 1.4-1.8 micron average size and having about 0.75 to 1.25 micrograms of dna per 720 micorgrams of tungsten; bombarding by accelerating at a high pressure from 7.25 centimeters
10/31/2000US6140554 Specificity of gene expression
10/31/2000US6140553 Incubating culture of monocotyledonous plant cells on medium including plant phenolic compound to stimulate cell division and enhance competence, then contacting with dna fragment for transformation and stable insertion into the genome
10/31/2000US6140552 Transgenic or chimeric cattle whose mammary gland cells contain a nucleic acid construct of dna encoding a signal sequence, a polypeptide of interest and a regulatory sequence; for production of heterologous proteins in milk
10/31/2000US6140500 The new dyes are brighter and permeate cells faster than currently available red-emitting live-cell nucleic acid stains.
10/31/2000US6140496 Precursors for deoxyribonucleotides containing non-standard nucleosides
10/31/2000US6140493 Method of synthesizing diverse collections of oligomers
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140491 Enzymatic nucleic acid which cleaves ribonucleic acids; has hammerhead motif and has at least one sugar-sugar backbone linkage which is different from a phosphodiester linkage; more stable than ribozymes; antisense agents; viricides
10/31/2000US6140490 Pure and non-naturally occurring rna specific rna sequence and capable of binding to c1q; identified through selex method; for drugs which suppress and activate the complement system and for diagnostic agents
10/31/2000US6140489 Compositions for sorting polynucleotides
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140487 DNA encoding kojibiose phosphorylase obtainable from thermoanaerobium, ' its preparation and uses
10/31/2000US6140486 Isolated nucleic acid having a defined nucleotide sequence from vibrio marinus; for production docosahexanoic acid in transgenic plants; nutrients; dietetics
10/31/2000US6140484 Bax ω protein and methods
10/31/2000US6140483 Human polyhomeotic 2 (hph2) acts as a tumor suppressor
10/31/2000US6140473 Antibodies specific for MTS2 Polypeptide
10/31/2000US6140472 Use of chimeric vaccinia virus complement control proteins to inhibit complement
10/31/2000US6140471 Methods for producing members of specific binding pairs
10/31/2000US6140468 Obtained by recombinant dna technology using baculovirus expression system; has defined n-terminal amino acid sequence; does not complex with alpha-1-antichymotrypsin or alpha-2-macroglobulin; does not degrade specific substrates
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140464 Nonapeptides that bind a HLA-A2.1 molecule
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140132 Amino acid sequence of modified aequorea green fluorescent protein having specific substitutions; for determining ph in cellular organelles
10/31/2000US6140129 Introducing flp recombination target sites permanently at random in the chromosomes using plasmid vector, mapping the sites, cloning the dna into a plasmid vector, removing origin of replication, introducing the vector into the bacteria
10/31/2000US6140128 Mixing calcium divalent cation, phosphate multivalent anion and the desired nucleic acid to form precipitation mixture, then incubating for 10 to 60 minutes to form particles
10/31/2000US6140126 Oligonucleotides which target untranslated regions coding a transcription factor; for treatment of cancer and inflamamation; anticarcinogenic agents; antiinflammatory agents
10/31/2000US6140125 Antisense inhibition of bcl-6 expression
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6140120 Regulated transcription of targeted genes and other biological events
10/31/2000US6140117 Ninjurin
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140115 Nucleotide sequences coding a mammalian enzymatic protein; for detection of mammalian genetic disorder and gene therapy
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
10/31/2000US6140111 Nucleotide sequences utilized for the treatment of genetic disorders in human and animal somatic cells
10/31/2000US6140104 Nucleic acids which code for an insecticidal protein agains beetles; pesticides; biological pest control
10/31/2000US6140103 Regulated protein expression in stably transfected mammalian cells
10/31/2000US6140101 Nucleotide sequences coding a protein with enzymatic activity; for the treatment of tumors; antitumor agents
10/31/2000US6140100 Cell-targeting molecule comprising a mutant human carboxypeptidase A
10/31/2000US6140096 Nucleotide sequence coding polypeptide with hydrolase activity; for the degradation of glucans, plant cell walls and microorganism cell walls
10/31/2000US6140095 Alkalitolerant xylanases
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/31/2000US6140088 With an amino acid dehydrogenase in the presence of ammonia and a co-factor
10/31/2000US6140087 Kit for making viral plasmid for treatment of genetic disorders; gene therapy
10/31/2000US6140086 Methods and compositions for cloning nucleic acid molecules
10/31/2000US6140085 Genetic control of flowering
10/31/2000US6140082 Nucleotide sequences comprising bordetella regulatory sequences; for the expression of heterologous proteins
10/31/2000US6140081 Nucleotide binding polypeptide; for efficient use as diagnostic tools in gene therapy and transgenic cells
10/31/2000US6140080 Promoter elements conferring root-preferred gene expression
10/31/2000US6140078 Derivable from a lactic acid bacterium in isolation from the coding sequence normally controlled by said promoter in a wild-type lactic acid bacterium
10/31/2000US6140077 Method for producing phytase
10/31/2000US6140076 Ig superfamily `dlair` receptors expressed in monocytes
10/31/2000US6140075 Method for producing antibodies and protein toxins in plant cells
10/31/2000US6140073 Useful in the promotion of tissue repair
10/31/2000US6140072 Functional recombinantly prepared synthetic protein polymer
10/31/2000US6140071 Proteins with mutations to decrease N-terminal methylation
10/31/2000US6140067 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
10/31/2000US6140064 Identifying ligands, and inhibitors (e.g., antagonists) or promoters (e.g., agonists) of receptor function, including methods in which host cells comprising a nucleic acid encoding a cxcr3 or variant thereof are used in an assay to identify
10/31/2000US6140061 Response regulator
10/31/2000US6140059 Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
10/31/2000US6140055 Detecting and quantitating target nucleic acid molecules in a sample via nucleic acid amplification
10/31/2000US6140054 Multiplex genotyping using fluorescent hybridization probes
10/31/2000US6140052 Diagnosing and treating cancers by determining the presence or absence in a cell of wild-type adenomatous polyposis coli (apc) or a wild-type downstream protein in the apc transcription regulatory pathway
10/31/2000US6140044 Methods and devices for packaging a substrate having an array of probes fabricated on its surface are disclosed
10/31/2000US6140042 TAB1 protein and DNA coding therefore
10/31/2000US6139902 Phytase and gene encoding said phytase
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/31/2000US6139834 Capable of killing human tumor cells in vivo; exhibits hypersensitivity to anti-viral agents
10/31/2000US6139833 Comprehensive system for gene discovery using retroviruses that have been engineered to exhibit increased accessibility to genomic dna, or to mutate and identify the chromosomal target sequences of dna binding proteins
10/31/2000US6139832 Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
10/31/2000US6139817 Identifying varying levels of genes essential to infectivity and growth of a pathogen through use of an expression vector system which uses a promoter that is ?off? in vitro, and turns ?on? selectively during a phase of the infection
10/31/2000US6139782 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes
10/31/2000CA2197684C Human-murine chimeric antibodies against respiratory syncytial virus
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2081885C Increased starch content in plants
10/31/2000CA2025605C Method of purifying human serum albumin
10/31/2000CA2009403C A packaging defective hiv provirus, cell lines, and uses thereof
1 ... 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 ... 4023